Preoperative treatment selection in rectal cancer: A population-based cohort study
Introduction
During the past decades treatment of rectal cancer has evolved dramatically. The introduction of total mesorectal excision (TME), has set focus on the importance of surgical technique for survival and local control.1 The Dutch TME trial showed that short-course preoperative radiotherapy (RT) in combination with TME surgery further reduced local recurrence rates while the effect on survival is not yet proven for all patients.2 For locally advanced tumours, long-course RT in combination with chemotherapy (CRT), improves local control and cancer-specific survival.3 However, RT, at least as it has been given during past decades, is also associated with side effects such as impaired healing, anorectal and genitourinary dysfunction, and secondary malignancies.4, 5, 6, 7, 8 Furthermore, because RT is cost and resource demanding it is of vital importance to identify patients in whom the benefits of RT exceed the risks.
Prior to commencement of therapy it is recommended that rectal cancer patients should be discussed at a multidisciplinary team conference (MDT). There are several guidelines, no one universally accepted, regarding the selection to different therapeutic options.9, 10, 11 The European guidelines suggest subdivision of rectal cancer according to the preoperative magnetic resonance imaging (MRI) into 3 groups: early, intermediate or locally advanced. However, the terminology and grouping varies in different guidelines.9, 10, 12 The extent to which guidelines are followed is poorly known and there is also uncertainty about the impact from various preoperative parameters on treatment decisions. Previous studies have reported inequalities regarding gender, ethnicity and socioeconomic status with respect to preoperative therapy.13, 14, 15 Moreover, age and comorbidity have a strong impact on preoperative treatment decisions16, 17 and increasing age and comorbidity among rectal cancer patients further adds complexity into the MDT-process.18 Because patients with advanced comorbidity and old age often are excluded from participation in clinical trials, knowledge on treatment selection in this sub-population is limited.19
This study aimed to investigate the clinical factors affecting the selection to preoperative treatment in a large population-based, prospectively registered cohort of rectal cancer patients.
Section snippets
Study population
The Swedish Rectal Cancer Registry (SRCR) was established in 1995 and has a coverage of >98%. The register is locally administered by the Regional Cancer Centres (RCC) and all patients are registered prospectively. Data on all patients who underwent elective trans-abdominal surgery for rectal cancer between January 2000 and December 2010 in the Stockholm-Gotland area (population 1.9 million) were extracted. Information retrieved included type of surgery, age, gender, date of diagnosis and
Clinical characteristics
A total of 2619 patients underwent elective transabdominal surgery for primary rectal cancer between 2000 and 2010. Descriptive data are shown in Table 2. More patients were operated in high volume centres in 2007–2010 compared to 2000–2002 (46.9% versus 37.2%, p < 0.001).
Preoperative RT (or CRT)
Among all patients 1789 (68.3%) had preoperative RT (or CRT). Table 3 shows the logistic regression analyses of the associations between clinical factors and preoperative treatment. Patients ≥80 years and patients with CCI
Discussion
This population-based study evaluated the associations between clinical characteristics and selection to preoperative oncological treatment in patients undergoing surgery for primary rectal cancer. In accordance with results from multiple studies showing lowered recurrence rates with preoperative (C)RT,2 patients were offered preoperative treatment to a high extent. However, without any obvious reason and despite increased knowledge about late adverse effects the use of preoperative (C)RT
Conflict of interest
None.
Acknowledgements
This work has been funded by the Regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. Financial support was also provided by the Swedish Cancer Society and the Stockholm Cancer Society. Thanks to Tongplaew Singnomklao, data manager at RCC.
References (29)
- et al.
Recurrence and survival after total mesorectal excision for rectal cancer
Lancet
(1986) - et al.
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Lancet Oncol
(2011) - et al.
Sexual function in males after radiotherapy for rectal cancer
Int J Radiat Oncol Biol Phys
(2010) - et al.
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
Ann Oncol
(2012) - et al.
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
Radiother Oncol
(2009) - et al.
Gender differences in the treatment of rectal cancer: a population based study
Eur J Surg Oncol
(2009) - et al.
Socioeconomic inequalities in the use of radiotherapy for rectal cancer: a nationwide study
Eur J Cancer
(2011) - et al.
Controversies of total mesorectal excision for rectal cancer in elderly patients
Lancet Oncol
(2008) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing
Eur J Surg Oncol
(2013)
Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older
Eur J Surg Oncol
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
J Clin Oncol
Occurrence of second cancers in patients treated with radiotherapy for rectal cancer
J Clin Oncol
Sexual function in females after radiotherapy for rectal cancer
Acta Oncol
Cited by (19)
Experience with age discrimination and attitudes toward ageism in older patients with cancer and their caregivers: A nationwide Korean survey
2019, Journal of Geriatric OncologyCitation Excerpt :Additionally, some older patients thought they have not received as much attention or supportive care as younger patients did, implying that older people are more sensitive to emotional and supportive care issues than to the actual treatment they receive. However, to our knowledge, previous studies regarding age-related discrimination focused mainly on the intensity of treatment [6–9] and did not pay much attention to these issues. Interestingly, ageist attitudes from patients themselves were related to whether they reported any experience of age discrimination.
Preoperative chemoradiotherapy for rectal cancer and impact on outcomes – A population-based study
2017, Radiotherapy and OncologyImpact of pre-treatment patient-related selection parameters on outcome in rectal cancer
2016, European Journal of Surgical OncologyCitation Excerpt :However, despite the risk of an increased proportion of treatment-related complications in the elderly population or in patients with significant comorbidity, there are results indicating that also these patients gain from preoperative treatment.9,12,19 In an earlier study we found that not only under-treatment is a problem in the selection process to preoperative treatment.7 Over-treatment with preoperative therapy in rectal cancer patients will increase postoperative morbidity with limited effect on outcome such as recurrence rates and survival.20–24
Survival among clinical stage I–III rectal cancer patients treated with different preoperative treatments: A population-based comparison
2016, Cancer EpidemiologyCitation Excerpt :Cancer registries are an important source of information since they provide accurate and comprehensive information on individual demographics, primary cancer sites and histology, cancer staging and surgical, radiation and systemic therapy. Dutch, Swedish, Danish and Norwegian cancer registries reported on colorectal cancer patients before [16–19]. However, little is known about the effect of preoperative and postoperative treatment and of the type of surgery on population-based rectal cancer survival in Belgium.